BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10810957)

  • 1. Urogenital atrophy and low-dose vaginal estrogen therapy.
    Notelovitz M
    Menopause; 2000; 7(3):140-2. PubMed ID: 10810957
    [No Abstract]   [Full Text] [Related]  

  • 2. Estrogens and the urogenital tract. Studies on steroid hormone receptors and a clinical study on a new estradiol-releasing vaginal ring.
    Smith P
    Acta Obstet Gynecol Scand Suppl; 1993; 157():1-26. PubMed ID: 8393609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current overview of the management of urogenital atrophy in women with breast cancer.
    Pruthi S; Simon JA; Early AP
    Breast J; 2011; 17(4):403-8. PubMed ID: 21645165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Topical hormonal treatment and urogenital atrophy].
    Sitruk-Ware R; Thomas JL
    Praxis (Bern 1994); 1997 Aug; 86(33):1245-8. PubMed ID: 9381009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen ring use for genitourinary atrophy and menopausal symptomatology.
    Thacker HL
    Geriatrics; 2004 May; 59(5):34, 36-7. PubMed ID: 15152734
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect and safety of 17 beta-estradiol vaginal tablet in postmenopausal women with urogenital symptoms.
    Manonai J; Theppisai U; Chittacharoen A
    J Med Assoc Thai; 2001 Jul; 84(7):1015-20. PubMed ID: 11759960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estradiol-releasing vaginal ring delivery system for urogenital atrophy. Experience over the past decade.
    Bachmann G
    J Reprod Med; 1998 Nov; 43(11):991-8. PubMed ID: 9839269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet.
    Weisberg E; Ayton R; Darling G; Farrell E; Murkies A; O'Neill S; Kirkegard Y; Fraser IS
    Climacteric; 2005 Mar; 8(1):83-92. PubMed ID: 15804736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oestradiol-releasing vaginal ring for treatment of postmenopausal urogenital atrophy.
    Smith P; Heimer G; Lindskog M; Ulmsten U
    Maturitas; 1993 Mar; 16(2):145-54. PubMed ID: 8483427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal ring an HT alternative.
    Cothran MM; Engberg S
    Nurse Pract; 2004 Jul; 29(7):54-5. PubMed ID: 15238860
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of vaginal estrogen in Danish women: a nationwide cross-sectional study.
    Meaidi A; Goukasian I; Lidegaard O
    Acta Obstet Gynecol Scand; 2016 Mar; 95(3):280-4. PubMed ID: 26646469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal rings for continuous low-dose release of oestradiol in the treatment of urogenital atrophy.
    Holmgren PA; Lindskog M; von Schoultz B
    Maturitas; 1989 Mar; 11(1):55-63. PubMed ID: 2498619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vagifem. A new low-dosage estradiol preparation for local treatment of postmenopausal urogenital atrophy].
    Eriksen PS; Rasmussen H
    Ugeskr Laeger; 1992 Apr; 154(16):1122-4. PubMed ID: 1523727
    [No Abstract]   [Full Text] [Related]  

  • 14. Vaginal administration of low-dose oestradiol--effects on the endometrium and vaginal cytology.
    Mattsson LA; Cullberg G; Eriksson O; Knutsson F
    Maturitas; 1989 Sep; 11(3):217-22. PubMed ID: 2593865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing urogenital atrophy.
    Palacios S
    Maturitas; 2009 Aug; 63(4):315-8. PubMed ID: 19493638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urogenital atrophy. A new approach to vaginitis diagnosis.
    Carcio H
    Adv Nurse Pract; 2002 Oct; 10(10):40-8, 51. PubMed ID: 12424883
    [No Abstract]   [Full Text] [Related]  

  • 17. Urogenital atrophy.
    Brown KH; Hammond CB
    Obstet Gynecol Clin North Am; 1987 Mar; 14(1):13-32. PubMed ID: 3627655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overactive bladder.
    Margraf C
    Am J Nurs; 2002 Oct; 102(10):14; author reply 14. PubMed ID: 12449925
    [No Abstract]   [Full Text] [Related]  

  • 19. Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet.
    Simon J; Nachtigall L; Gut R; Lang E; Archer DF; Utian W
    Obstet Gynecol; 2008 Nov; 112(5):1053-60. PubMed ID: 18978105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal hormone therapy for urogenital and menopausal symptoms.
    Ballagh SA
    Semin Reprod Med; 2005 May; 23(2):126-40. PubMed ID: 15852198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.